Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Compounding Enforcement Could Have Been More Aggressive, Hamburg Acknowledges; Tense Hearing Continues Legislative Stalemate

This article was originally published in The Pink Sheet Daily

Executive Summary

House Republicans remain unconvinced that FDA needs additional enforcement powers as Commissioner Hamburg is grilled on why the agency didn’t employ its current forceful inspection approach in the run-up to New England Compounding Center tragedy.

Advertisement

Related Content

FDA Compounder Inspections May Help Set New Enforcement Standard

Topics

Advertisement
UsernamePublicRestriction

Register

PS075533

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel